文献速递腹部CT

对比增强CT上被漏诊的肝转移瘤的影像学特征

Imaging Characteristics of Liver Metastases Overlooked at Contrast-Enhanced CT.
PubMed 文献 · AJR Am J Roentgenol · 2019-02-19

回顾2010年11月至2017年9月746例结直肠癌、乳腺癌、胃癌或肺癌肝转移患者,分析首次诊断时及既往增强CT图像,将137个病灶分为漏诊组68个与检出组,漏诊病灶对比噪声比显著更低,被膜下位置、肝脂肪变及非肿瘤评估检查指征的比值比显著更高。

要点

  • 对比噪声比低的肝转移灶在增强CT上易被漏诊。
  • 肝脂肪变患者、被膜下病灶及非肿瘤评估指征检查时漏诊风险更高。
  • 阅片时应特别关注被膜下区域及肝脂肪变背景下的低对比强化病灶。

核心结论

  • 对比增强不足的肝转移灶、肝脂肪变患者的病灶、被膜下位置的病灶以及在非评估肿瘤指征检查中发现的病灶显著更易被漏诊。

研究设计与样本

  • 回顾性分析2010年11月至2017年9月746例结直肠癌、乳腺癌、胃癌或肺癌肝转移患者的记录,复查首次诊断时及既往对比增强CT图像,最终分析137个病灶,采用t检验和Fisher精确检验比较漏诊组与检出组的影像特征。

关键影像表现/征象

  • 漏诊病灶的对比噪声比显著低于检出病灶(95%CI,2.65±0.24 vs 3.90±0.23;p<0.001)。
  • 漏诊病灶中被膜下病灶比例显著更高(比值比3.44;p<0.001)。
  • 漏诊病灶中肝脂肪变比例显著更高(比值比6.35;p=0.007)。
  • 漏诊病灶中检查指征为非肿瘤评估的比例显著更高(比值比9.07;p=0.02)。

诊断标准与关键数值

  • 漏诊病灶对比噪声比95%CI为2.65±0.24,检出病灶为3.90±0.23(p<0.001)。
  • 被膜下病灶漏诊比值比为3.44(p<0.001)。
  • 肝脂肪变患者病灶漏诊比值比为6.35(p=0.007)。
  • 非肿瘤评估检查指征发现的病灶漏诊比值比为9.07(p=0.02)。

临床应用与阅片要点

  • 阅片时需关注对比增强不充分的肝病灶,尤其在被膜下区域。
  • 肝脂肪变背景可能增加肝转移灶漏诊风险。
  • 非肿瘤评估指征的增强CT检查中应留意肝转移灶的排查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to evaluate the imaging characteristics of liver metastases overlooked at contrast-enhanced CT.

MATERIALS AND METHODS: The records of 746 patients with a diagnosis of liver metastases from colorectal, breast, gastric, or lung cancer between November 2010 and September 2017 were reviewed. Images were reviewed when liver metastases were first diagnosed, and images from prior contrast-enhanced CT examinations were checked if available. These lesions were classified into two groups: missed lesions (those missed on the prior images) and detected lesions (those correctly identified and invisible on the prior images or there were no prior images). Tumor size, contrast-to-noise ratio, location, presence of coexisting liver cysts and hepatic steatosis, and indications for examination were compared between the groups. The t test and Fisher exact test were used to analyze the imaging characteristics of previously overlooked lesions.

RESULTS: The final analysis included 137 lesions, of which 68 were classified as missed. In univariate analysis, contrast-to-noise ratio was significantly lower in missed lesions (95% CI, 2.65 ± 0.24 vs 3.90 ± 0.23; p < 0.001). The proportion of subcapsular lesions (odds ratio, 3.44; p < 0.001), hepatic steatosis (odds ratio, 6.35; p = 0.007), and examination indication other than survey of malignant tumors (odds ratio, 9.07; p = 0.02) were significantly higher for missed lesions.

CONCLUSION: Liver metastases without sufficient contrast enhancement, those in patients with hepatic steatosis, those in subcapsular locations, and those found at examinations for indications other than to assess for tumors were significantly more likely to be overlooked.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Nakai H, Arizono S, Isoda H, et al. Imaging Characteristics of Liver Metastases Overlooked at Contrast-Enhanced CT. AJR Am J Roentgenol. 2019. PMID: 30779660. doi:10.2214/AJR.18.20526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。